+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Other Building Blocks 1005334-57-5
1005334-57-5,MFCD18072197
Catalog No.:AA008SQ4

1005334-57-5 | 3-(((3-(4-(Methylsulfonamido)phenyl)-4-oxo-4H-chromen-7-yl)oxy)methyl)benzoic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$58.00   $40.00
- +
5mg
≥98%
in stock  
$169.00   $118.00
- +
10mg
98% by HPLC
in stock  
$283.00   $198.00
- +
25mg
98% by HPLC
in stock  
$528.00   $370.00
- +
50mg
98% by HPLC
in stock  
$854.00   $598.00
- +
100mg
98% by HPLC
in stock  
$1,431.00   $1,002.00
- +
500mg
98% by HPLC
in stock  
$4,477.00   $3,134.00
- +
1000mg
98% by HPLC
in stock  
$7,126.00   $4,988.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA008SQ4
Chemical Name:
3-(((3-(4-(Methylsulfonamido)phenyl)-4-oxo-4H-chromen-7-yl)oxy)methyl)benzoic acid
CAS Number:
1005334-57-5
Molecular Formula:
C24H19NO7S
Molecular Weight:
465.4752
MDL Number:
MFCD18072197
SMILES:
OC(=O)c1cccc(c1)COc1ccc2c(c1)occ(c2=O)c1ccc(cc1)NS(=O)(=O)C
Properties
Computed Properties
 
Complexity:
857  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
33  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
7  
XLogP3:
3.1  

Downstream Synthesis Route

[1]CurrentPatentAssignee:AMYGDALANEUROSCIENCESINC-US2008/32995,2008,A1Locationinpatent:Page/Pagecolumn31

[2]CurrentPatentAssignee:GILEADSCIENCESINC;THEENDOWMENTFORRESEARCHINHUMANBIOLOGYINC-WO2009/94028,2009,A1Locationinpatent:Page/Pagecolumn81

[1]CurrentPatentAssignee:GILEADSCIENCESINC;THEENDOWMENTFORRESEARCHINHUMANBIOLOGYINC-WO2009/94028,2009,A1Locationinpatent:Page/Pagecolumn84

[1]CurrentPatentAssignee:AMYGDALANEUROSCIENCESINC-US2008/32995,2008,A1

[2]CurrentPatentAssignee:GILEADSCIENCESINC;THEENDOWMENTFORRESEARCHINHUMANBIOLOGYINC-WO2009/94028,2009,A1

[1]CurrentPatentAssignee:AMYGDALANEUROSCIENCESINC-US2008/32995,2008,A1

[2]CurrentPatentAssignee:GILEADSCIENCESINC;THEENDOWMENTFORRESEARCHINHUMANBIOLOGYINC-WO2009/94028,2009,A1

Literature

Title: Novel medication targets for the treatment of alcoholism: preclinical studies.

Journal: Recent patents on CNS drug discovery 20120801

Title: Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis.

Journal: Nature medicine 20100901

Title: A selective ALDH-2 inhibitor reduces anxiety in rats.

Journal: Pharmacology, biochemistry, and behavior 20091201

Title: Overstreet DH, et al. A selective ALDH-2 inhibitor reduces anxiety in rats.Pharmacol Biochem Behav. 2009 Dec;94(2):255-61.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1005334-57-5
Building Blocks
More >
Tags:1005334-57-5 Molecular Formula|1005334-57-5 MDL|1005334-57-5 SMILES|1005334-57-5 3-(((3-(4-(Methylsulfonamido)phenyl)-4-oxo-4H-chromen-7-yl)oxy)methyl)benzoic acid